GC Biopharma has won a $44.38 million flu vaccine

This article is translated by AI company Flitto and Alhpa Biz neural machine translation technology

Kim Jisun Reporter

stockmk2020@alphabiz.co.kr | 2023-03-21 06:18:55

GC녹십자 (사진=GC녹십자)

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] GCGC Biopharma announced on the 20th that it has won a $44.38 million (KRW 57.9 billion) flu vaccine in a bid for medicine in the Southern Hemisphere in 2023. The export will be supplied to Latin American countries during the first half of the year.

According to global market research firm Evaluate Pharma, the global flu vaccine market is expected to grow rapidly to $7.4 billion in 2025.

The Green Cross has topped the PAHO's list of flu vaccines for the past 10 years from 2014 to this year.

 

[ⓒ 알파경제. 무단전재-재배포 금지]